MiMedx Group Inc (MDXG)
9.25
+0.03
(+0.33%)
USD |
NASDAQ |
Nov 22, 12:10
MiMedx Group Shareholders Equity (Quarterly): 181.01M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 181.01M |
June 30, 2024 | 168.04M |
March 31, 2024 | 155.73M |
December 31, 2023 | 142.72M |
September 30, 2023 | 1.33M |
June 30, 2023 | -12.67M |
March 31, 2023 | -17.95M |
December 31, 2022 | -17.99M |
September 30, 2022 | -19.52M |
June 30, 2022 | -13.60M |
March 31, 2022 | -7.434M |
December 31, 2021 | 0.082M |
September 30, 2021 | -5.808M |
June 30, 2021 | -7.137M |
March 31, 2021 | -8.051M |
December 31, 2020 | -0.15M |
September 30, 2020 | 12.87M |
June 30, 2020 | 22.86M |
March 31, 2020 | 30.34M |
December 31, 2019 | 34.40M |
September 30, 2019 | 39.58M |
June 30, 2019 | 24.68M |
March 31, 2019 | 38.35M |
December 31, 2018 | 49.66M |
December 31, 2017 | 73.80M |
Date | Value |
---|---|
September 30, 2017 | 142.47M |
June 30, 2017 | 147.27M |
March 31, 2017 | 129.04M |
December 31, 2016 | 133.00M |
September 30, 2016 | 123.28M |
June 30, 2016 | 121.60M |
March 31, 2016 | 114.24M |
December 31, 2015 | 107.99M |
September 30, 2015 | 100.52M |
June 30, 2015 | 93.24M |
March 31, 2015 | 86.40M |
December 31, 2014 | 89.33M |
September 30, 2014 | 81.26M |
June 30, 2014 | 74.49M |
March 31, 2014 | 76.24M |
December 31, 2013 | 73.57M |
September 30, 2013 | 35.54M |
June 30, 2013 | 32.89M |
March 31, 2013 | 31.59M |
December 31, 2012 | 20.01M |
September 30, 2012 | 19.18M |
June 30, 2012 | 15.67M |
March 31, 2012 | 12.50M |
December 31, 2011 | 11.90M |
September 30, 2011 | 11.85M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-19.52M
Minimum
Sep 2022
181.01M
Maximum
Sep 2024
31.95M
Average
-0.034M
Median
Shareholders Equity (Quarterly) Benchmarks
CEL-SCI Corp | 8.473M |
AIM ImmunoTech Inc | 2.912M |
IGC Pharma Inc | 7.377M |
NovaBay Pharmaceuticals Inc | 1.072M |
Protalix BioTherapeutics Inc | 32.44M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 243.89M |
Total Liabilities (Quarterly) | 62.88M |
Debt to Equity Ratio | 0.1051 |
Current Ratio | 4.104 |
Net Debt Paydown Yield | 0.69% |